New drugs: where did we go wrong and what can we do better?
BMJ
.
2019 Jul 10:366:l4340.
doi: 10.1136/bmj.l4340.
Authors
Beate Wieseler
1
,
Natalie McGauran
2
,
Thomas Kaiser
2
Affiliations
1
Institute for Quality and Efficiency in Health Care, Cologne, Germany beate.wieseler@iqwig.de.
2
Institute for Quality and Efficiency in Health Care, Cologne, Germany.
PMID:
31292109
DOI:
10.1136/bmj.l4340
No abstract available
MeSH terms
Drug Approval* / legislation & jurisprudence
Drug Costs
Drug Development / standards
Drug Evaluation / standards
Evidence-Based Medicine
Germany
Humans